Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 5mg | $41.99$25.20 | $5.04/mg | In stock | Jul 8 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| CJD06261105J | May 2026 | 99.5% | Janoshik Analytical | Endotoxin | Unverified | View |
| — | May 2026 | 99.7% | Janoshik Analytical | — |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. CJC-1295 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Verified Peptides sell CJC-1295?
Yes — Verified Peptides currently lists CJC-1295 in 1 variant starting at $25.20 ($5.04/mg).
Is Verified Peptides's CJC-1295 third-party tested?
Yes — Disclosed Labs has indexed 21 Certificates of Analysis for Verified Peptides's CJC-1295, with the most recent showing 99.5% purity. Verified Peptides holds an overall trust grade of C (79/100) across all 364 COAs on file.
What is Verified Peptides's trust grade for CJC-1295?
Verified Peptides has an overall Disclosed Labs trust grade of C (79/100), computed from 364 COAs across all peptides. The most recent CJC-1295 COA was issued by Janoshik Analytical.
Where is the cheapest CJC-1295?
As of the latest data, Peptide Supply Co. offers CJC-1295 at $3.80/mg — compare with Verified Peptides's listing at $5.04/mg. See the full CJC-1295 price comparison.
Is CJC-1295 legal to buy?
CJC-1295 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| Unverified |
| View |
| — | Apr 2026 | 99.8% | Janoshik Analytical | — | Unverified | View |
| — | Mar 2026 | 98.0% | Janoshik Analytical | — | Unverified | View |
| CJD032610051 | Feb 2026 | 99.3% | Janoshik Analytical | — | Confirmed | View |
| 01-26-0905H | Dec 2025 | 99.4% | Janoshik Analytical | — | Unverified | View |
| CJND01260810E | Dec 2025 | — | Janoshik Analytical | Endotoxin | Confirmed | View |
| — | Dec 2025 | 99.0% | Janoshik Analytical | — | Unverified | View |
| 10-25-0710G | Oct 2025 | 99.3% | Janoshik Analytical | — | Unverified | View |
| 10-25-08056 | Sep 2025 | 99.4% | Janoshik Analytical | — | Unverified | View |
| 09-24-0505F | Feb 2025 | 98.9% | Janoshik Analytical | Endotoxin | Confirmed | View |
| 07-24-0505E | Oct 2024 | 99.5% | Janoshik Analytical | Endotoxin | Unverified | View |
| 20224E | May 2024 | 99.7% | Janoshik Analytical | — | Unverified | View |
| 10423D | Jan 2024 | 99.7% | Janoshik Analytical | — | Unverified | View |
| — | Dec 2023 | 99.7% | Janoshik Analytical | — | Unverified | View |
| 26652D | Nov 2023 | 99.0% | Janoshik Analytical | — | Unverified | View |
| 61223C | May 2023 | 99.8% | Janoshik Analytical | — | Unverified | View |
| 78612B | Nov 2022 | 96.9% | Janoshik Analytical | — | Unverified | View |
| 65497A | Feb 2021 | 99.3% | Janoshik Analytical | — | Unverified | View |
| 13955A | Jun 2020 | 100.0% | Janoshik Analytical | — | Unverified | View |
| — | Nov 2019 | 98.0% | Janoshik Analytical | — | Unverified | View |